Applied Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Applied Therapeutics, Inc. (APLT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are APLT insiders buying or selling?
In the last 12 months, Applied Therapeutics, Inc. insiders reported 0 open-market purchases ($0) and 1 sale ($4.8K) — net selling of $4.8K. Since May 2019, Trabud has recorded 78 Form 4 filings for APLT: 14 buys ($17.9M) and 64 sells ($27.7M).
Source: SEC EDGAR Form 4
What stands out
- No Applied Therapeutics, Inc. insider made an open-market purchase in the last 12 months; the 1 reported open-market sale totaled $4.8K.
Key Statistics (May 2019 – Dec 18, 2025)
Total Form 4 filings
78
SEC EDGAR
Insider filers
10
Insider buys (14)
$17.9M
Insider sells (64)
$27.7M
Insider sentiment
Net sellingNet insider flow of $9.8M in net selling since May 2019, and $4.8K in net selling over the last 12 months.
Recent APLT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Stacy J. Kanter | Director | Sale | 43.0K | $0.11 | $4.8K | SEC ↗ |
| Mar 7, 2025 | Riccardo Perfetti | Chief Medical Officer | Sale | 10.4K | $0.44 | $4.6K | SEC ↗ |
| Mar 7, 2025 | Leslie D. Funtleyder | Interim Chief Executive Officer and Chief Financial Officer | Sale | 14.5K | $0.44 | $6.4K | SEC ↗ |
| Mar 7, 2025 | Constantine Chinoporos | Chief Operating Officer and Chief Business Officer | Sale | 447 | $0.44 | $196.68 | SEC ↗ |
| Feb 8, 2025 | Leslie D. Funtleyder | Interim Chief Executive Officer and Chief Financial Officer | Sale | 22.9K | $0.61 | $14.0K | SEC ↗ |
| Feb 8, 2025 | Riccardo Perfetti | Chief Medical Officer | Sale | 86.1K | $0.61 | $52.5K | SEC ↗ |
| Feb 8, 2025 | Constantine Chinoporos | Chief Operating Officer and Chief Business Officer | Sale | 28.1K | $0.61 | $17.2K | SEC ↗ |
| Aug 23, 2024 | Leslie D. Funtleyder | Chief Financial Officer | Sale | 13.5K | $5.83 | $78.9K | SEC ↗ |
| Aug 23, 2024 | Riccardo Perfetti | Chief Medical Officer | Sale | 22.7K | $5.83 | $132.2K | SEC ↗ |
| Aug 14, 2024 | Shendelman Shoshana | President and CEO | Sale | 777.0K | $6.06 | $4.7M | SEC ↗ |
| Jun 10, 2024 | Shendelman Shoshana | President and CEO | Sale | 61.8K | $4.32 | $267.0K | SEC ↗ |
| Jun 10, 2024 | Riccardo Perfetti | Chief Medical Officer | Sale | 22.0K | $4.32 | $95.1K | SEC ↗ |
| Jun 10, 2024 | Leslie D. Funtleyder | Chief Financial Officer | Sale | 17.0K | $4.32 | $73.4K | SEC ↗ |
| Jun 6, 2024 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% Owner | Sale | 300.0K | $4.23 | $1.3M | SEC ↗ |
| Mar 18, 2024 | Shendelman Shoshana | President and CEO | Sale | 318.6K | $5.39 | $1.7M | SEC ↗ |
| Mar 18, 2024 | Riccardo Perfetti | Chief Medical Officer | Sale | 110.8K | $5.39 | $597.2K | SEC ↗ |
| Mar 18, 2024 | Adam Hansard | Chief Commercial Officer | Sale | 48.9K | $5.39 | $263.4K | SEC ↗ |
| Mar 18, 2024 | Leslie D. Funtleyder | Chief Financial Officer | Sale | 28.7K | $5.39 | $154.8K | SEC ↗ |
| Dec 6, 2023 | Stacy J. Kanter | Director | Purchase | 30.0K | $2.18 | $65.4K | SEC ↗ |
| Dec 2, 2023 | Shendelman Shoshana | President and CEO | Sale | 4.0K | $1.97 | $7.8K | SEC ↗ |
| Dec 2, 2023 | Riccardo Perfetti | Chief Medical Officer | Sale | 1.6K | $1.97 | $3.1K | SEC ↗ |
| Dec 2, 2023 | Adam Hansard | Chief Commercial Officer | Sale | 965 | $1.97 | $1.9K | SEC ↗ |
| Nov 6, 2023 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% Owner | Sale | 247.3K | $2.31 | $572.2K | SEC ↗ |
| Nov 2, 2023 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% Owner | Sale | 327.7K | $2.38 | $781.2K | SEC ↗ |
| Sep 30, 2023 | Shendelman Shoshana | President and CEO | Sale | 115.6K | $2.70 | $312.2K | SEC ↗ |
Showing the 25 most recent of 78 Form 4 filings for Applied Therapeutics, Inc..
Most active APLT insiders
- Riccardo Perfetti29 filings
- Shendelman Shoshana14 filings
- Leslie D. Funtleyder13 filings
- ALEXANDRIA REAL ESTATE EQUITIES, INC.6 filings
- Adam Hansard5 filings
Ask anything about APLT insider activity
Use Trabud's AI agent to query Applied Therapeutics, Inc.'s Form 4 history in plain English — "Show me APLT CEO purchases this year" or compare it against any other ticker.
Open the AI agentAPLT insider trading FAQ
Are Applied Therapeutics, Inc. insiders buying or selling?
In the last 12 months, Applied Therapeutics, Inc. insiders reported 0 open-market purchases ($0) and 1 sale ($4.8K) — net selling of $4.8K. Since May 2019, Trabud has recorded 78 Form 4 filings for APLT: 14 buys ($17.9M) and 64 sells ($27.7M). Over the full record that is net selling of $9.8M.
How many insiders trade APLT stock?
10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Applied Therapeutics, Inc.. The most recent filing was accepted on Dec 18, 2025.
Where does Trabud get APLT insider trading data?
All APLT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.